title: Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.
authors.forename: D B
authors.initials: DB
authors.lastname: Hunninghake
authors.forename: J M
authors.initials: JM
authors.lastname: McKenney
authors.forename: A M
authors.initials: AM
authors.lastname: Gotto
authors.forename: J L
authors.initials: JL
authors.lastname: Mehta
authors.forename: P H
authors.initials: PH
authors.lastname: Jones
mesh_terms: D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D019468:Disease Management; D005569:Formularies as Topic; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008329:Managed Care Programs; D010349:Patient Compliance; D012307:Risk Factors; D014481:United States
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL